Saturday, July 25, 2026

Patent directory · USPTO A61K / A61P

Patents matching “ABBVIE INC [US]”

4 pharma patents match "ABBVIE INC [US]" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 1,585
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "ABBVIE INC [US]" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “ABBVIE INC [US]” · 1,585 patents in full index Clear search

  1. WO 2025221754

    UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES

    ABBVIE INC [US] · Granted Oct 23, 2025 · Expires Oct 18, 2045

    granted
  2. WO 2025137347

    FORMULATIONS DE RISANKIZUMAB À HAUTE CONCENTRATION

    ABBVIE INC [US] · Granted Jun 26, 2025 · Expires Jun 21, 2045

    granted
  3. US 2024398790

    TREATING SPONDYLOARTHRITIC CONDITIONS WITH UPADACITINIB

    ABBVIE INC [US] · Granted Dec 5, 2024 · Expires Nov 30, 2044

    granted
  4. US 2024390367

    METHODS OF TREATING VITILIGO WITH UPADACITINIB

    ABBVIE INC [US] · Granted Nov 28, 2024 · Expires Nov 23, 2044

    granted